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Abstract The current, static methodologies for measuring
cyclic AMP (cAMP) may underestimate its regulatory proper-
ties. Here, we have exploited the Ca2+-conducting properties of
cyclic nucleotide-gated (CNG) channels to measure cAMP in live
cells, in response to various stimuli. We placed a mutated CNG
channel with high sensitivity to cAMP in adenovirus to maximize
and render facile its expression in numerous cell types. The
ready, continuous nature of the readout contrasted with the
traditional approach, which yielded similar static information,
but lacked any continuous or interactive qualities. It seems fair to
predict that this readily adopted approach will broaden the
perception of cAMP signaling. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Cyclic AMP (cAMP) is the prototypical second messenger,
which has established the model of second messenger cascades
comprised of kinases, phosphatases and, more recently, an-
choring proteins. Nevertheless, this messenger may possess
important regulatory features that have eluded us so far.
For instance, it has been formally proposed that cAMP levels
^ like cytosolic calcium concentration ([Ca2]i) ^ can oscillate
[1,2]. As with oscillations in [Ca2]i, similar changes in cAMP
might also suggest hitherto unexpected signaling modes for
cAMP. However, the observation of dynamic changes in
cAMP ^ necessarily in living cells ^ is precluded by available
methodologies. The pioneering studies of Sutherland and col-
leagues applied a bioassay for cell extracts of cAMP by the
activation of glycogenolysis [3]. The uncertainties and com-
plexities surrounding this approach were circumvented by the
application of a protein binding assay [4,5] and radioimmuno-
assays of extracted cAMP. Later the activation of cAMP-de-
pendent protein kinase (PKA) was used as a measure of
cAMP levels [6]. All of these approaches su¡er from the mea-
surement of static accumulated levels of cAMP, which pre-
cludes the possibility of seeing dynamic and continuous
changes. A step towards a continuous method has been de-
scribed that involves changes in £uorescence resonance energy
transfer (FRET) between the two subunits of £uorescently
tagged PKA upon the elevation of cellular cAMP [7]. This
method initially required the microinjection of labeled sub-
units into the cytosol of single cells. The problems associated
with microinjection into cells have now been addressed [8] by
heterologously expressing genetically encoded subunits of
PKA fused with green £uorescent protein (GFP) constructs.
However, the modest signal-to-noise associated with the
change in FRET upon binding cAMP, coupled with slow
reassociation of the subunits and association of GFP-labeled
subunits with endogenous PKA subunits limit the utility of
this approach. We recently developed a method for measuring
cAMP using the electrical properties of the olfactory cyclic
nucleotide-gated (CNG) channel encoded in an adenovirus
vector to maximize its expression. We ¢rst showed that the
native channel could measure cAMP in the domain of the
plasma membrane, in which it was synthesized by using elec-
trophysiological measurements of the channel activity in re-
sponse to the activation of adenylyl cyclase or to exogenous
cyclic nucleotides [9]. However, the CNG channel is also a
Ca2 channel [10] and therefore the increase in [Ca2]i could
be followed £uorometrically, as a measure of the activation of
adenylyl cyclase. In the present study we have adopted a pub-
lished mutation that increases the channel’s sensitivity to
cAMP over cGMP, and used this version encoded in adeno-
virus to measure cAMP in populations and single cells. We
show that the method allows the facile detection of a L2-ad-
renergic receptor coupled to adenylyl cyclase in C6-2B cells
with appropriate pharmacology. Adenylyl cyclase activity can
also be seen to rapidly respond to receptor stimulation, fol-
lowed by antagonism, or inhibition, succeeded by re-stimula-
tion by forskolin. A continuous readout of cAMP accumula-
tion in the domain where it is synthesized is possible in either
populations of cells in a spectro£uorimeter or potentially in
single cells by £uorescence imaging. This ability to monitor
cAMP continuously provides a dramatic opportunity to read-
ily assess adenylyl cyclase activity in situ in response to chang-
ing stimuli, which promises to have wide-ranging application.
2. Materials and methods
2.1. Materials
Thapsigargin and forskolin were from Calbiochem (La Jolla, CA,
USA). [2-3H]Adenine, [3H]cAMP, and [K-32P]ATP were obtained
from Amersham Corp. (Arlington Heights, IL, USA). Fura-2/AM
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and pluronic F-127 were from Molecular Probes, Inc. (Eugene, OR,
USA). Other reagents were from Sigma (St. Louis, MO, USA).
2.2. Construction of CNG channel-encoding adenovirus
The E583M mutation to the wild type (WT) olfactory CNG chan-
nel was generated using the QuickChange Site-Directed Mutagenesis
kit (Stratagene). The E583M channel-encoding adenovirus was con-
structed as described previously for the WT channel [11].
2.3. Tissue culture and channel expression
C6-2B glioma cells were maintained in culture and infected with
adenovirus as described previously [11].
2.4. Measurement of cAMP accumulation
Static cAMP accumulation in intact cells was measured as described
previously [12] with some modi¢cations. C6-2B cells on 100 mm
dishes were incubated in F-10 medium (90 min at 37‡C) with
[2-3H]adenine (20 WCi/dish) to label the ATP pool. The cells were
then washed once, detached with phosphate-bu¡ered saline containing
EDTA (0.03%), and resuspended in a nominally Ca2-free Krebs bu¡-
er containing 120 mM NaCl, 4.75 mM KCl, 1.44 mM MgSO4, 11 mM
glucose, 25 mM HEPES, and 0.1% bovine serum albumin (fraction
V), adjusted to pH 7.4 with 2 M Tris base. Experiments were con-
ducted in the presence of the phosphodiesterase (PDE) inhibitor,
3-isobutyl-1-methylxanthine (IBMX; 100 WM), and Ca2 (2 mM),
which was preincubated with the cells for 5 min prior to assay at
room temperature. Aliquots (900 Wl) were removed every 10 s and
immediately added to trichloroacetic acid (TCA; 100 Wl ; 100%; w/v
¢nal) to terminate the reaction. After pelleting, the [3H]ATP and
[3H]cAMP contents of the supernatant were quanti¢ed as described
previously [13]. Accumulation of cAMP is expressed as the conversion
of [3H]ATP into [3H]cAMP.
2.5. [Ca2+]i measurements
Detached cells (10U106/ml) were loaded with fura-2/AM (2 WM)
plus 0.02% pluronic acid in F-10 media (without serum, containing
HEPES 20 mM, 0.1% bovine serum albumin, pH 7.4) for 25 min at
room temperature, and [Ca2]i measurements were made as previ-
ously described [11]. Cells were maintained in Krebs media (as above,
without bovine serum albumin) containing Ca2 (2 mM) throughout,
unless stated otherwise. The results are expressed as the ratio of the
emissions from 340/380 nm excitation. The data presented are repre-
sentative of at least three similar experiments.
3. Results
The ability of CNG channels to conduct Ca2 [10] provides
a potentially simple and rapid means to estimate endoge-
nously synthesized or exogenously applied cyclic nucleotides
by monitoring fura-2 £uorescence. Indeed, we had shown ear-
lier that the WT olfactory CNG channel expressed in C6-2B
cells responded with a modest rise in [Ca2]i following expo-
sure to high concentrations of the cell permeant cGMP ana-
log, 8-p-chlorophenylthio-cGMP [11]. In addition, we had
shown that in cells stably expressing high activities of adenylyl
cyclase type 8, su⁄cient cAMP was produced in response to
forskolin that a rise in [Ca2]i was detected [9]. However,
there are two drawbacks to the use of WT CNG channels
to detect increases in cAMP. First, WT channels have a low
apparent a⁄nity for cAMP, which curtails their ability to
detect the low cAMP concentrations that activate PKA
[14,15]. Second, these channels are activated more readily by
cGMP than cAMP [16], which might generate ambiguities in
some situations. To overcome these problems, we modi¢ed
the WT CNG channel to increase its a⁄nity for cAMP and
decrease its a⁄nity for cGMP. Mutation of the highly homol-
ogous, rod CNG channel at D604 to methionine was previ-
ously shown to both increase the cAMP a⁄nity and decrease
the sensitivity to cGMP [17]. Methionine is naturally found at
this position in several cAMP binding domains, such as that
of the bovine cAMP-dependent kinase IIa domain B and the
rat olfactory CNG channel subunit 2 [18,19]. Therefore, we
modi¢ed the analogous residue in the WT olfactory CNG
channel K subunit, E583, to methionine.
The rise in [Ca2]i was compared in populations of C6-2B
cells, a rat glioma cell line which is non-excitable, infected
with either the WT or E583M CNG channel adenovirus, in
response to increasing concentrations of the L-adrenergic re-
ceptor agonist, isoproterenol, added at 300 s (Fig. 1). The WT
CNG channel is modestly stimulated by 100 nM isoproterenol
(black trace) and only weakly stimulated by 1 nM isoproter-
enol (yellow trace, Fig. 1A). In contrast, much more rapid
responses are yielded by the E583M CNG channel when ex-
posed to the same isoproterenol concentrations (Fig. 1B). The
[Ca2]i rises generated by the two CNG channels at a given
isoproterenol concentration are quite di¡erent with respect to
both the slope of the rising phase and the time to half-max-
imal stimulation (t50). In the case of 10 nM isoproterenol, the
WT CNG channel reaches a half-maximal value in 140 s,
while the E583M CNG channel reaches a half-maximal value
in 68 s. Similarly, the slope of the rising phase after treating
the cells with 10 nM isoproterenol is 0.0058 for the WT CNG
channel, compared with 0.0191 for the E583M CNG channel.
Therefore, the E583M CNG channel generates a [Ca2]i rise
that is both faster and more robust than the WT CNG chan-
nel, which is consistent with the greater sensitivity of the mu-
tant channel to cAMP. Under conditions of maximal adenylyl
cyclase stimulation (10 WM isoproterenol, 10 WM forskolin),
the di¡erences in the kinetics of the response in cells express-
ing the WT CNG channel (black trace) or the E583M CNG
channel (red trace) are readily evident (Fig. 1C). Furthermore,
with maximal adenylyl cyclase activation, both the WT- and
E583M CNG channel-expressing cells elicit similar maximal
responses, indicating that the extent of channel expression was
similar. Control, uninfected cells showed no response to either
isoproterenol or IBMX, nor did infected cells in the absence
C
Fig. 1. Adenovirus-mediated expression of WT and E583M CNG
channels in C6-2B cells. C6-2B cells were infected with the indicated
CNG channel construct at a multiplicity of infection of 100, 48 h
prior to [Ca2]i measurements. [Ca2]i was determined in aliquots
of 4U106 fura-2-loaded C6-2B cells, as described in Section 2. Cells
expressing either the WT (A) or E583M (B) CNG channels were
maintained in Krebs medium containing 2 mM Ca2. The cells were
pretreated with IBMX (100 WM) 5 min prior to the addition of
varying isoproterenol concentrations at 300 s (1 nM, yellow trace;
3 nM, green trace; 10 nM, red trace; 100 nM, black trace), along
with forskolin (1 WM) to increase the signal, particularly in the case
of the WT channel. The time to half-maximal stimulation (t50) fol-
lowing stimulation with either 1 nM, 3 nM, 10 nM, or 30 nM iso-
proterenol was 186 s, 176 s, 140 s, and 113 s, respectively, for the
WT channel and 107 s, 86 s, 68 s, and 56 s, respectively, for the
E583M mutant channel. Insets: plot of the slope of the rising phase
(U100) versus the isoproterenol concentration in cells infected with
either the WT channel (A, inset) or the E583M mutant channel (B,
inset). With maximal adenylyl cyclase stimulation (10 WM isoproter-
enol, 10 WM forskolin; added at 300 s), the peak of the [Ca2]i rise
generated by both CNG channels (E583M, red trace; WT, black
trace) is similar, although again the rate of the rise is much faster
with E583M CNG channel, indicating that the two CNG channels
are expressed at similar levels (C). Uninfected cells showed no re-
sponse to isoproterenol (not shown). The resultant [Ca2]i rise is de-
picted as an increase in the ratio of the emissions following 340/380
excitation.
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of extracellular Ca2 (data not shown; i.e. none of these
agents promotes Ca2 release from intracellular stores). The
E583M channel was used in all further experiments.
We next wished to test the application of the E583M CNG
channel as a sensor for changes in [cAMP]i in a simulated
receptor screening exercise. We compared the magnitude of
the [Ca2]i rise produced by varying concentrations of three L-
adrenergic receptor agonists, which stimulate adenylyl cyclase
via Gs. Populations of C6-2B cells were treated with increas-
ing concentrations of either isoproterenol, epinephrine, or
norepinephrine, ranging from 1 to 1000 nM (Fig. 2). Isopro-
terenol was the most e¡ective, giving a slight increase of 340/
380 £uorescence at 1 nM, a very robust stimulation at 10 nM,
and a maximal stimulation at 100 nM. Epinephrine was
slightly less e¡ective, with the £uorescence traces shifted to
the right. Norepinephrine was very impotent in eliciting any
increase in 340/380 £uorescence, even at the highest concen-
tration. This agonist potency order of isoproterenols epi-
nephrineEnorepinephrine is the classic order expected for
L2-adrenergic receptors [20], which are expressed in C6-2B
cells [21]. Control, uninfected cells did not yield a response
to any of the L-adrenergic agonists used (data not shown).
This result shows not only the ability of the E583M CNG
channel to act as a sensor for cAMP, but also that the sensor
can be used to identify receptor subtypes in a particular cell,
and thereby allow screening of potential receptor agonists.
If the CNG channel could also respond to decreases in
cAMP, this would permit the study of G-protein-coupled re-
ceptor antagonists, as well as inhibitors of adenylyl cyclase.
To determine whether the sensor could re£ect decreases in
cAMP, populations of C6-2B cells were ¢rst stimulated with
isoproterenol, followed by the L-adrenergic receptor antago-
nist, propranolol (Fig. 3A). Addition of propranolol (100 WM)
30 s after isoproterenol (1 WM) showed a rapid decrease in the
340/380 £uorescence (Fig. 3C), as compared to isoproterenol
alone (Fig. 3A). Gi-mediated inhibition of isoproterenol stim-
ulation was also examined. 2-Methylthioadenosine 5P-triphos-
phate (2MeSATP; 100 nM) which is a P2Y-purinergic receptor
agonist that only couples to Gi in C6-2B cells [22], signi¢-
cantly decreased 340/380 £uorescence compared to the control
(Fig. 3B). Neither propranolol nor 2MeSATP produced a
response in control, uninfected cells or in cells which were
not stimulated with isoproterenol (data not shown). This ex-
periment was conducted in the presence of the PDE inhibitor,
IBMX, to maximize the signal and to more accurately re£ect
changes in adenylyl cyclase activity. However, to examine
‘net’ cAMP changes, which would be the sum of cAMP syn-
thesis by adenylyl cyclase and cAMP degradation by PDE,
and to accentuate the inhibitory response [23], the ability of
the E583M CNG channel to report changes in cAMP in the
absence of PDE inhibitors was also examined. In the same set
Fig. 2. Comparison of the e⁄cacy of three L-adrenergic receptor ag-
onists using the E583M CNG channel. Fura-2-loaded C6-2B cells
infected with the E583M CNG channel construct were incubated in
Krebs medium containing 2 mM Ca2 and pretreated with IBMX
(100 WM) 5 min prior to the addition of the L-adrenergic receptor
agonists. Increasing concentrations of either isoproterenol (black
trace), epinephrine (red trace), or norepinephrine (green trace) were
added as follows: 300 s, 1 nM; 450 s, 10 nM; 600 s, 100 nM; 750
s, 1000 nM. None of these agents produced a response in control,
uninfected cells (not shown).
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of cells as in Fig. 3A, in the absence of IBMX, isoproterenol
gave a robust increase in 340/380 £uorescence (Fig. 3B),
although the magnitude was smaller than in the presence of
IBMX (cf. Fig. 3A). However, under these conditions, both
propranolol and 2MeSATP rapidly eliminated the signal elic-
ited by isoproterenol. This more rapid inhibitory e¡ect in the
absence of PDE inhibitors would be expected, given that
background PDE can have profound e¡ects on cAMP levels
[23]. The observed rapidity of elimination of the cAMP signal
speaks for the utility of this assay in physiological conditions.
As a further measure of the ability of this sensor to respond
to changes in cAMP, the action of the adenylyl cyclase inhib-
itor 2P,5P-dideoxyadenosine (ddA) was examined (Fig. 3C).
Populations of C6-2B cells were treated with isoproterenol
(1 WM) at 300 s, resulting in a rapid rise in 340/380 £uores-
cence. Addition of ddA (100 WM) either prior to (180 s) or
after (330 s) isoproterenol addition resulted in a greatly di-
minished signal, with the prior treatment being more e¡ective.
It is interesting to note that in in vitro adenylyl cyclase assays,
ddA is extremely e¡ective at inhibiting adenylyl cyclase activ-
ity [24], while in vivo, the inhibitory e¡ects of ddA are limited
by its ability to cross the plasma membrane. This conclusion
is supported in the present experiment showing that ddA is
more e¡ective at longer incubation times and generates only
partial inhibition of adenylyl cyclase at these times. Conse-
quently, this assay could be used to quickly optimize the
time of preincubation of a slowly permeating agent.
The traditional cAMP accumulation assay was compared
with the continuous assay developed here using the CNG
channel under the same experimental conditions as those ap-
plied in Fig. 3 (Fig. 4). Populations of C6-2B cells in Krebs
medium containing 2 mM Ca2 were pretreated with the PDE
inhibitor, IBMX. Aliquots were removed every 10 s and im-
mediately placed into TCA, followed by determination of the
Fig. 3. Detection of decreases in [cAMP]i using the E583M CNG
channel following receptor antagonism or adenylyl cyclase inhibi-
tion. Fura-2-loaded C6-2B cells infected with the E583M CNG
channel were incubated in Krebs medium containing 2 mM Ca2.
A,B: Cells were pretreated with either IBMX (A, 100 WM) or ve-
hicle alone (B, DMSO) 5 min prior to the addition of isoproterenol
(1 WM; 300 s), followed by the addition of either vehicle alone
(water; black trace), 2MeSATP (100 nM; green trace), or proprano-
lol (100 WM; red trace) at 330 s. C: Cells were pretreated with
IBMX (100 WM) 5 min prior to the addition of isoproterenol (1
WM; 300 s; black trace). The adenylyl cyclase inhibitor ddA (100
WM) was added either prior to (180 s; red trace) or following (330
s; green trace) the isoproterenol addition.
Fig. 4. Measurement of adenylyl cyclase activity by a conventional,
static method. C6-2B cells were incubated with [3H]adenine to label
the ATP pool, washed and resuspended in Krebs medium contain-
ing 2 mM Ca2, as described in Section 2. Populations of C6-2B
cells were pretreated with the PDE inhibitor IBMX 5 min prior to
assay. Aliquots were removed every 10 s and immediately placed
into TCA, followed by determination of the [3H]cAMP and
[3H]ATP. At 25 s, isoproterenol (1 WM) was added, followed by ei-
ther no addition (circles), propranolol (100 WM; triangles), or 2Me-
SATP (100 nM; squares) at 55 s. The results are expressed as the
percent conversion of [3H]ATP to [3H]cAMP.
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[3H]cAMP and [3H]ATP contents [12,13]. At 25 s, isoproter-
enol (1 WM) was added, followed either by no addition, pro-
pranolol (100 WM), or 2MeSATP (100 nM) at 55 s. Propra-
nolol was the most e¡ective, while 2MeSATP, acting via Gi,
was intermediate in its ability to decrease the amount of
cAMP accumulated. These results mirrored the ¢nding using
the E583M channel as a sensor for cAMP accumulation, and
thereby validate the use of that assay. However, the continu-
ous readout from the CNG channel assay and the facility of
obtaining those data contrast with the more laborious, tradi-
tional method.
A particularly useful attribute of this sensor over more
standard means of determining cAMP accumulation is its
ability to generate a ‘continuous’ readout. This is exempli¢ed
by the sequential addition of a series of agonists and antago-
nists. In Fig. 5, C6-2B cells were initially stimulated with iso-
proterenol (1 WM) at 300 s, followed by the addition of the L-
adrenergic antagonist, propranolol (100 WM), at 330 s and
¢nally, the adenylyl cyclase activator, forskolin (50 WM), at
600 s. The cells responded to this series of agents by showing
an increase in 340/380 £uorescence with isoproterenol, which
was subsequently decreased by propranolol and then in-
creased again in response to forskolin. Therefore, the impact
of a series of agents that a¡ect cAMP accumulation can be
monitored sequentially, which provides a great improvement
over static modes of studying cAMP1.
4. Discussion
The use of the Ca2-conducting properties of a modi¢ed
CNG channel as a sensor for changes in cAMP concentration
provides the ¢rst readily applicable and continuous method-
ology for monitoring cAMP levels in living cells. We have
shown that the application of the CNG channel as a sensor
is made extremely easy due to its insertion in adenovirus,
which allows high and easily controlled expression in a wide
variety of cell types, coupled with the fact that the readout is
in the form of a [Ca2]i rise, which is a widely available, real-
time measurement. Furthermore, expression of the CNG
channel does not interfere with the cell’s Ca2 or cAMP ho-
meostasis ; Ca2 release and capacitative Ca2 entry are the
same in uninfected and infected cells, as is the production of
cAMP, as judged by traditional cAMP assays (not shown). Of
course, because changes in [Ca2]i are used as the readout and
many factors can impinge on Ca2 homeostasis, the measure-
ments are qualitative and caution must be exercised in apply-
ing mechanistic conclusions. For instance, depolarization of
excitable cells would be accompanied by a robust [Ca2]i rise,
which could overwhelm any signal originating from the CNG
channel. However, as with any other methodology, awareness
of the basis of the method should minimize any misleading
interpretations. The mutant channel allows the ready detec-
tion of the modest amounts of cAMP formed in response to
very low concentrations of isoproterenol. Adrenergic receptor
subtypes, or others that might be coupled to adenylyl cyclase
in other cell types, are rapidly identi¢able. The localization of
the cAMP sensor at the plasma membrane is a major advan-
tage, which allows the measurement of cAMP concentrations
in the domain of the cell, where many of the actions of cAMP
take place, for instance, the activation of PKA bound to A-
kinase-anchoring proteins near the plasma membrane. Be-
cause cAMP is measured locally, alterations in cAMP accu-
mulation brought about by local PDE activity or receptor
desensitization, for example, could be monitored continuously
and compared with global measurements, using traditional
cAMP determinations. The ability to detect changes in
cAMP concentration continuously in living cells provides a
signi¢cant improvement over the traditional, static methods
for measuring cAMP accumulation. As with current method-
ologies for assaying cAMP accumulation, the present method-
ology does not provide absolute values for cAMP. However,
this approach provides a simple system for applications such
as screening potential receptor agonists and antagonists that
are coupled to adenylyl cyclase, determining factors that in-
£uence PDE activity and assessing the cell permeability of
agents that act on the cAMP system, such as P-site inhibitors
and forskolin. Another possible application of this cAMP
sensor is the ability to measure cAMP in single cells. Polarized
cells, like epithelial cells, or those with elaborate morpholo-
gies, such as neurons, or identi¢able sub-populations of cells,
may show localized changes in cAMP concentration in re-
sponse to selective agents. It is already well documented
that apparently homogeneous populations of cells respond
heterogeneously to agents that are coupled to rises in InsP3.
For instance, single cell Ca2 imaging experiments reveal het-
erogeneity in the [Ca2]i response in individual cells promoted
by various PLC-coupled receptor agonists [25,26]. The same
situation may apply to agents coupled to the stimulation or
inhibition of adenylyl cyclase. Furthermore, it must be
stressed that oscillations in cAMP, like oscillations in
[Ca2]i, can only be discerned at the single cell level. Unless
oscillations are coordinated, individual responses are averaged
in a population. These and other issues that could not readily
be addressed by static methodologies can now be approached.
In signaling, conceptual developments are dictated by the
information content of the methodologies for measuring the
Fig. 5. Continuous measurement of sequential activation and inhibi-
tion of adenylyl cyclase activity. Fura-2-loaded C6-2B cells infected
with the E583M CNG channel were incubated in Ca2-containing
(2 mM) Krebs medium and pretreated with IBMX (100 WM) 5 min
prior to the sequential additions of isoproterenol (1 WM; 300 s),
propranolol (100 WM; 330 s), and forskolin (50 WM; 600 s).
1 These experiments were performed on cells in suspension in a stirred
cuvette. Thus, none of the reagents was removed. However, the ex-
periment could be readily adopted to cells attached to a coverslip with
agents continually exchanging by perfusion of the cuvette.
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second messengers. Thus, the dynamic, single living cell meth-
ods that were developed for the study of [Ca2]i allowed the
discovery of [Ca2]i oscillations, the profusion of theories for
their origins, along with searches for how they might be used
in signaling. In contrast, due to the static and cell-sacri¢cing
methodologies for studying cAMP, the possibility that cAMP
levels might change dynamically, although theoretically sup-
ported, could not be realistically considered. Thus, it is pos-
sible that fundamental aspects of cAMP signaling are being
overlooked. We would hope that the development of this
methodology will provide a stimulus for considering a broader
range of signaling options for cAMP.
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